Dr. Lagares is a serial scientist-entrepreneur, company builder, and operator with +18 years of experience translating breakthrough science into therapeutic innovation. His former laboratory at Harvard Medical School and Massachusetts General Hospital pioneered first-in-class “mechano-therapeutics” and “senolytics,” uncovering novel mechanisms involved in aging, fibrosis, and cancer and identifying new therapeutic approaches to regenerate chronically damaged organs. These discoveries, published in leading journals including Nature and Science, led to patented therapeutic platforms and the creation of two Boston-based biotech companies, Mediar Therapeutics and Zenon Biotech. These innovations have advanced programs from target discovery to Phase 2 clinical trials. Today, Dr. Lagares serves as Founder, CEO, and President of Zenon Biotech, where he leads the development of first-in-class therapeutics targeting mechanobiology-driven diseases. His career sits at the intersection of scientific discovery and entrepreneurship: translating pioneering science into medicines for patients.

Dr. Lagares earned his Ph.D. from the Autonomous University of Madrid, completed postdoctoral training at Massachusetts General Hospital/Harvard, and previously served as Professor of Medicine at Harvard Medical School. He earned his MBA from MIT Sloan School of Management.